Privigen is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Privigen is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand namePrivigen
Authorized generichuman immunoglobulin G
Regular generichuman immunoglobulin G
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Privigen?
The original
–
–

Brand nameThe maker’s card

Privigen Copay Support Program (Privigen Connect)

Savings card from CSL Behring

No insuranceNeeds insuranceNo cash price listed.
Insurance $0

The card takes up to $20,000 a year off your co-pay.

Sign up on privigen.com 

Or call 1-877-355-4447.

In the maker’s words

“Most people with commercial insurance pay $0 out-of-pocket…”

From the maker’s offer on privigen.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Privigen itself, from the same company, sold without the brand name, and usually for less. For now Privigen is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Privigen is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

PRIVIGEN is an Immune Globulin Intravenous (Human), 10% Liquid indicated for the treatment of:

  • Primary humoral immunodeficiency (PI)
  • Chronic immune thrombocytopenic purpura (ITP) in patients aged 15 years and older
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults

Limitations of Use:

Maintenance therapy in CIDP has not been studied beyond 6 months.

Source: the FDA label for Privigen (CSL Behring AG), May 4, 2026. Full label on DailyMed 

Good to know